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D
ental implants have proven to
be a viable, highly predictable
option for supporting prosthetic
rehabilitations. Thanks to the phenom-
enon of osseointegration, they rehabil-
itate missing teeth.1
To achieve said osseointegration,
primary stability is of the essence.2 It is
acquired by surgically preparing the
implant bed and inserting the implant.
Osseointegration is defined as the im-
plant’s resistance to movement from
axial, lateral, and rotational forces and
is dependent on a number of factors: the
implant’s macroscopic design, the sur-
gical technique, and bone density.3–6
During the healingperiod, a remod-
eling of the bone tissue occurs, and
bone apposition can be observed
between the implant’s threads. This re-
sults from an increase in the bone-
implant interface7 known as secondary
stability. On a clinical level, this was
initially characterized as decreased primary stability, critical period during
which there is an increased risk of mi-
cromovements, which may lead to defi-
cient osseointegration.8 As such, it is
important to have at one’s disposal
diagnostic tools that will allow one to
establish the minimum implant stability
necessary, so as to reduce the risk of
micromovements and any complica-
tions resulting from them during the
process.9
One of the most widely used meth-
ods for analyzing primary and second-
ary stability is the resonance frequency
analysis (RFA).10–13 It is a noninvasive
diagnostic system that evaluates the
rigidity of the bone–implant interface
to assign quantitative values. With
these values, once is able to evaluate,
albeit indirectly, the implant’s stability.
The most recent RFA system for clini-
cal use is Ostell Mentor (Osstell AB,
Gothenburg, Sweden), which uses
a transducer (SmartPeg) screwed into
the implant. The implant can be ac-
cessed through electromagnetic pulses
generated by a portable device, which
gathers numerical values correspond-
ing to the so-called implant stability
quotient (ISQ). These values can range
from 1 to 100, with one representing
very little stability. Furthermore, this
system allows one to repeat and repro-
duce values almost perfectly.9
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Purpose: The purpose of this
prospective study is to evaluate the
relationship between implant diame-
ter, and primary and secondary
stability.
Materials and methods: Five
hundred fifty-nine implants with di-
ameters of 3.7, 4.0, and 4.3 mm and
lengths of 10 and 11.5 mm were
placed in 195 patients. The reso-
nance frequency was measured dur-
ing surgery and at 3, 6, and 12
months.
Results: Related average
implant stability quotient (ISQ) val-
ues were 69.62 for 3.7-mm implants,
72.02 for 4.0-mm implants, and
69.67 for 4.3-mm implants. Values
in men were greater than values in
women. Values were greater for the
mandible than for the maxilla. There
are significant differences between
4.0-mm implants, and 3.7 anterior
maxilla and 4.3 posterior maxilla.
Conclusions: There is no rela-
tionship between increased ISQ val-
ues and increased diameters. We
observed a preference regarding
sex, with men having significantly
greater values for 3.7- and 4.3-mm
diameters. The mandible obtained
the greatest ISQ values, with signif-
icant differences for diameters 3.7
and 4.3 mm. (Implant Dent
2019;28:279–288)
Key Words: implant diameter, pri-
mary and secondary implant stabil-
ity, implant stability quotient
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A number of studies have already
established a correlation between the ISQ
values and the implant’s degree of mobil-
ity regarding the bone tissue.11,14–16 Dif-
ferent variables may come into play, such
as bone quantity and quality, surgical
technique, and the implant’s geometry,
the length and the diameter.14,17–22 Also
to be taken into account is the correlation
between ISQ values and the healing pro-
cesses from the implant’s osseointegra-
tion, resulting in apositive prognosis.23–28
Given the discrepancy in the existing
literature regarding the geometric factors,
specifically the implants’ diameter,
which may impact primary stability, our
objective in this study is to evaluate the
role diameter plays in the primary and
secondary stability of dental implants,
using the RFA (in vivo) as our basis.
MATERIALS AND METHODS
Study Group
This prospective study was con-
ducted at theUniversidad FedericoHenrí-
quez y Carvajal’s (UFHEC) postgraduate
university clinic from 2016 to 2018.
To be able to participate in the
study, the following inclusion and
exclusion criteria were applied:
Inclusion Criteria
• ASA I patients
• Patients missing 1 or more teeth
(mandible or maxilla)
• Patients with no active periodontal
disease.
• Patients with sufficient bone quan-
tity for the length and diameter of
the implants (measured with
CBCT using a surgical stent to
establish implant placement site).
• Edentulous spaces with sufficient
keratinized gingiva.
• Posterior rehabilitation with ce-
mented crowns or bridges.
• No need for bone or mucosal
regeneration.
Exclusion Criteria
• Patients who did not meet the
inclusion criteria.
• Smokers.
• Patients who did not wish to par-
ticipate in the study.
• Patients with ASA II classification
or higher.
• Patients undergoing treatment or
who have received treatment with
bisphosphonates.
• Patients who have undergone or
are undergoing chemotherapy.
• Patients who are undergoing anti-
metabolic therapy.
• Pregnant women.
• Patients who had been treated with
antibiotics in the 3 months before
the first surgery.
• Toothless patients.
• Patients requiring additional bone
regeneration surgery during
implant insertion.
• Patients diagnosed at some point
with periodontal disease, treated
or untreated.
• Patients with bruxism.
• Patients who are allergic to
penicillin.
All patients were informed in detail
about the objectives and procedures of
the study, and theyweregiven, inwriting,
an informed consent, which they had to
accept to participate in the study.
Five hundred fifty-nine Zinic (Zia-
com Medical, SL., Madrid, Spain)
endosseous implants were used, with
diameters of 3.7, 4.0, and 4.3 mm and
lengths of 10 and 11.5mm.All implants
were titanium grade IV. The body
displayed active coils with a reduced
angle, double coil, transversal apical
windows, and atraumatic tip. In addi-
tion, they presented an internal hexag-
onal connection, conical bevel and
platform switch. All the implants used
in the study shared the same surface
treatment, thus the same macroporosity
and microporosity. The only variations
presentedwere length and diameter. All
the implants were placed by the same
operator.
The study was approved by Feder-
ico Henríquez y Carvajal University,
Ethical Committee (Approval number:
10/2010), and written consents by the
patients were obtained.
Surgical Procedure
The surgical procedure used to
insert the 559 implants included the
following phases:
First surgical phase (T0). Corresponds
to the insertion of the implant, with the
following guidelines being respected at
all times:
a. The surgical procedures were
performed by the same operator.
b. In cases where a tooth had to be
extracted before implant inser-
tion, we waited 3 months after
the extraction before commenc-
ing the surgical procedure.
c. Local, infiltrative anesthesia was
used, and the chosen anesthetic
was articaine with epinephrine
with a concentration of
1:200,000.
d. Using a no. 11 surgical blade, the
supracrestal and paracrestal inci-
sions were made (when the inserted
gum was less than 2 mm from the
median crest line to the mucogingi-
val line), and the papilla of the tooth
adjacent to the edentulous area was
respected at all times, keeping
a minimum distance of 1 mm.
e. We then proceeded to perform
the mucoperiosteal sweeping
(total thickness) using a Molt
periosteal elevator, and the surgi-
cal splints were positioned veri-
fying stability and direction.
f. The drilling sequence specified by
the manufacturer was then used.
g. All implants were inserted in the
bone tissue in a contra angle with
an insertion torque of at least 35
Ncm.
h. The final implant insertion was
performed manually with a ratchet
wrench.
i. We then proceeded to measure the
RFA with the Osstell Mentor, tak-
ing 2 measurements: vestibular and
lingual/palatine. To do this, we
manually screwed a SmartPeg into
the head of the implant requiring
measurement. The tube was then
inserted at a distance of 2 mm to
the transducer, forming a 90-degree
angle regarding the implant. The
same Osstell Mentor was used for
all measurements. To obtain the
ISQ values, 2 different transducers
were used to measure each implant.
In order for the measurement to be
considered valid, there could not be
a variation of 62 units for each
measurement between the 2 trans-
ducersdwith the median being
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considered. The corresponding
closing cap was put in place.
j. The closing of the mucoperiosteal
flap was performed with simple,
double-knot stitches with 3/0 thread
and 3/8 needle, triangular section,
half curve, and reverse cut.
k. At the end of the surgery, each
patient received 1 mL of betame-
thasone sodium phosphate/
betamethasone acetate, in sterile
aqueous suspension in an intra-
muscular manner, corresponding
to 6 mg.
l. Participants were also treated
with 875 mg of amoxicillin and
125 mg of clavulanic acid every
12 hours over the course of 5
days starting the day before the
surgery and 600 mg of ibuprofen
with arginine every 12 hours
over the course of 3 days starting
the day the implant was inserted.
In cases of moderate to severe
pain, the medication was supple-
mented with 575 mg of magne-
sium metamizole.
m.Patients were informed of the
required techniques to maintain
proper oral hygiene at the site
of the surgery using a surgical
toothbrush, as well as of the re-
maining teeth, and to apply chlo-
rhexidine 0.2% gel every 8 hours
for 10 days.
n. Stitches were removed 7 to 10
days after the implant was in-
serted.
o. During each intervention, note
was taken of the number of im-
plants inserted, the location, the
diameter, the length, and the ISQ
values obtained during the ves-
tibular and lingual measurements
of each implant.
Second surgical phase after surgery
(T1). Corresponded to the reopening
phase following the period of osseointe-
gration (3months after implant insertion),
to remove the closing cap and to place the
healingabutment.Local, infiltrative anes-
thesia was used, and the chosen anes-
thetic was articaine with epinephrine,
with a concentration of 1:200,000.
Two surgical techniques were used,
as per the clinical parameters in place:
a. Flap surgery with no movement
of tissue: When the level of in-
serted mucosa was between 2
and 5 mm, a supracrestal incision
was made halfway through the
width of the keratinized gingival
band, perpendicular to the
implant, and enabled the detach-
ment of a vestibular and lingual/
palatine mucoperiostic flap, al-
lowing access to the cover screw.
b. Flap technique with apical repo-
sitioning: It was performed when
the level of inserted mucosa was
less than or equal to 2 mm. We
followed the same principles as
in the previous technique, but
performing two, 1-mm vertical
sweeps up to the mucogingival
line.
In this second phase, the RFA was
measured using the same device and
following the same protocol as
described in the surgical procedure.
ISQ values obtained when measur-
ing the vestibular and lingual of each
implant were taken. The healing abut-
ment was inserted in accordance with
the manufacturer’s recommendations.
The closing of the mucoperiosteal flaps
was performed with simple, double-
knot stitches with 3/0 thread and 3/8
needle, triangular section, half curve,
and reverse cut. Patients were informed
of the required techniques to maintain
proper oral hygiene at the site of the
surgery using a surgical toothbrush, as
well as of the remaining teeth, and to
apply chlorhexidine 0.2% gel every 8
hours for 10 days and take 600 mg of
ibuprofen with arginine every 12 hours
that same day.
Prosthetic phase. It was performed 14
to 16 days after the second surgical
phase, using the open-tray technique for
impression taking.
The prostheses used were partial or
fixed, unique crowns in metal ceramic,
and never more than 3 pieces. The
crownswere cementedwith provisional
material.
First control phase (T2). It was per-
formed 6 months after the surgical
phase. The prosthetic rehabilitation
was removed, and the ISQ values
obtained previously were measured
once again following the same protocol
as in the surgical phase. All results were
compiled in the record and follow-up
table.
Second control phase (T3). It was
performed 1 year after the surgical
phase. Prosthetic rehabilitations were
removed, and the ISQ values obtained
previously were measured once again
following the same protocol as in the
surgical phase. All results were com-
piled in the record and follow-up table.
Statistical Analysis
Comparisons between the various
ISQ values were performed in accor-
dance with the following criteria:
• Significance level 5% (a value ¼
0.05)
• Comparison of median values per-
formed after a 2-queue model,
with no hypothesis: The average
of the first group is equal to the
average of the second group; alter-
native hypothesis: The average of
the first group is not equal to the
average of the second group.
• The most adequate method of
comparison was the T test with 2
independent variables (based on
the method of the t for Student),
as the samples being compared
were of different sizes and data
numbers generally .40.
• The results of the comparisons
were expressed in accordancewith
P value, as per the following val-
ues: IfP value,0.05 (significance
level), the differences noted in the
median values are considered sig-
nificant (with a 95% trust level).
RESULTS
A total of 195 patients were
selected with ages ranging from 25 to
68 years (average age 47.5). A total of
559 implants were inserted: 45.97% in
women and 54.03% in men, with the
number of implants placed inmenbeing
significantly greater than in women (P
value ¼ 0.007, 0.05).
In this study, men’s ISQ was 70.99
6 9.91 and women’s was 69 6 11.70,
a statistically significant difference (P-
value ¼ 0.000 , 0.05). When
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comparing results for diameter, we ob-
tained statistically significant differen-
ces for the 3.7-mm diameter (with
a value of 70.48 6 9.80 in men com-
pared with 68.47 6 10.87 in women),
and a P value ¼ 0.001. The same ap-
plies for diameter 4.3 mm (with an ISQ
median value of 71.51 6 9.19 in men
compared with women at 66.92 6
13.26) and a P value ¼ 0.000.
Of the 559 implants inserted, none
failed. In total, 278 were inserted in the
maxilla and 276 in the mandible. The
number of implants placed in posterior
sections was significantly greater than
the number placed in anterior sections
(206 posteriormaxilla implants and 245
posterior mandible) (P value ¼ 0.000).
When analyzing the median ISQ values
obtained, we observe that in the mandi-
ble, the value is of 71.186 11.08 com-
pared with 68.98 6 10.41 for the
maxilla, the difference being significant
with a P value ¼ 0.000.
When analyzing the diameters of the
implants, we observe that, most fre-
quently (325), the diameter is of 3.7 mm
(more frequent in men), followed by 112
units with a diameter of 4.0 mm (more
frequent in women) and 122 implants are
of 4.3 mm (more frequent in men).
The average ISQ values regarding
the diameters were of 69.62 6 for 3.7-
mm implants, 72.02 6 for 4-mm im-
plants and69.676 for 4.3-mm implants.
If we consider ISQ values in rela-
tion to the diameters and measuring
times (T0, T1, T2, and T3), we observe
significant differences for the diameter
of 4.0 mm in the T0, which obtained
greater ISQ values than the other diam-
eters. In T1, the relationship continues
to be statistically significant for im-
plants with a diameter of 4.0 mm and
those with a diameter of 4.3 mm. For
measurements taken at 6 months and 1
year, we did not observe statistically
significant differences between any of
the diameters (Fig. 1).
When breaking down these values
for measurements taken for vestibular
(V) and lingual/palatine (L), it can be
observed that, in T0, the values ob-
tained for Vwith a 4.0-mmdiameter are
significantly greater than for 3.7- and
4.3-mm implants. Conversely, the mea-
surement for L was only significantly
greater in 4.0 when compared with 4.3.
In T1, the L measurement maintains its
higher value for the 4.0-mm diameter,
when compared with the 4.3-mm L
implant. In contrast to the previous
results whereby a median for ISQ
values was established, in T2 and T3,
we can observe statistically significant
differences between 4.0- and 3.7-mm
diameters (with measurement for L in
T2 and V in T3) (Fig. 2).
When analyzing the relationship
between the diameter, implant site,
and absolute ISQ times and values,
one can observe a lack of significant
difference in the T0. However, when
breaking down the measurements for V
and L, it becomes clear, and signifi-
cantly so, that the values obtained in the
anterior maxilla (lingual) for 4.0-mm
implants versus 3.7-mm implants, dif-
fer (Fig. 3). In T1, we can also observe
statistically significant differences
when comparing absolute ISQ values
between implants with 4.0-mm diame-
ter located in the anterior maxilla and
with those of the 3.7-mm variety, with
the former having significantly greater
values than the latter. This affirmation is
also confirmedwhen breaking down the
values obtained for vestibular and lin-
gual for the same diameters (Fig. 4). At
6 months, T2, we can observe once
again that the implants with 4.0-mm
diameter present values greater than
those with 3.7 and 4.3 mm, with these
values being significant for posterior
maxilla, again for vestibular and lin-
gual. There is also a significant differ-
ence between the values of implants
with 4.0-mm diameter for lingual, with
greater value, compared with 4.3-mm
diameter in posterior maxilla (Fig. 5).
In the last measurement, in T3, we can
observe once again that absolute ISQ
values are significantly greater in the
anterior maxilla for 4.0-mm implants
than for 3.7 mm. When breaking down
the ISQvalues,we can observe that they
become greater for 4.0-mm diameter
(both vestibular and lingual), compared
with 3.7 mm. This is also the case when
we compare them with posterior max-
illa, vestibular, 4.3 mm (Fig. 6).
DISCUSSION
In the past years,many studies have
focussed on discovering the factors that
influence proper implant stability, both
primary and secondary. Said factors
have been described as quantity, bone
quality, surgical technique, and the
geometry of the implants, its length
and diameter.15,17–19
To objectify and obtain reproduc-
ible data, numerous studies have estab-
lished that the RFA is of great use for
measuring primary stability and evalu-
ating possible implant prognosis in
a noninvasive manner through ISQ
values.12,16,20,29–34
In this study, we wished to verify
whether implant diameter was at all
linked to ISQ values, as well as to verify
the relationship between diameter and
other factors such as sex, implant site in
the maxillaries, and surgical technique
and procedure. In this article, while
studying the ISQ values in relation to
the diameter, we did not observe a link
between a greater ISQ and a larger
diameter. In fact, in T0, we observed
significant differences between 4.0-mm
implants with a value of 71.966 11.35,
significantly greater than the3.7-mmim-
plants with a result of 68.646 10.11 (P
¼ 0.007) and those with the largest, 4.3-
mm diameter 69.68 6 11.51 (P ¼
0.041). When comparing these results
with the literature, we observed a certain
degree of controversy and lack of una-
nimity, which could be due to crown
size. In this study, 4.3-mm implants have
the same shape and size as the 3.7 and
4.0 mm ones, although the diameter of
the implant body increases for the 4.3.
The fact that they are the same size may
influence the stability coefficient: the
difference between the bone part of the
crown and the gap between the implant
part of the crown, due to the use of the
countersink.
There are reports of in vitro studies
that use animal bones as substrate, like
the study by Bilhan et al,16 who, in
2010, placed ninety 3.8- and 4.6-mm
implants and similarly, to this study,
did not find statistically significant dif-
ferences between the diameters and the
ISQ values. This coincides with the re-
sults obtained by Ohta et al33 in 2010,
who performed a study on 3.5-, 4.3-,
and 5-mm implants. Thesefindings also
coincide with the study on cadavers by
Pommer et al34 in 2012, who presented
no evidence of a significant difference
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between these 2 parameters. However,
the studies did not maintain the same
crown diameter. There have been other
studies on artificial bone, with widely
different results. Tözüm et al35 affirm
in 2008 that implants with a larger
diameter obtain higher ISQ values (3.7
vs 4.8 mm), unlike this study which es-
tablishes that the 4.0-mm implant main-
tains the greatest stability coefficient.
Barikani et al14 revealed that implants
with a narrow platform present signifi-
cantly lower ISQ when compared with
implants with regular and wide plat-
forms. This differs from this study,
which uses platforms of the exact same
size, with the only variation being the
diameter of the implant. In 2017, Hsu
et al36 only evidenced a significant
increase in ISQ in implants with a 6-
mm diameter. It is possible that the lack
of unanimity among these studies is due
to the fact theywere performed onmod-
els and not in vivo.
If we analyze the published results
of studies performed on living subjects
with a view to understanding the possi-
ble relationship between ISQ values
and implant diameter, we find that more
than half of the studies reviewed have
established a link between the high ISQ
values and greater implant diameter.
This is the case of Östman et al37 who in
2006 performed a clinical trial on 905
implants with diameters of 3.75, 4, and
5mm and found that the 5-mm implants
had a significantly greater primary sta-
bility. These authors argue that wider
implants tend to interlock more easily
with the cortical layers and, for that rea-
son, demonstrate greater primary stabil-
ity. In 2010, Degidi et al12 studied 4135
implants from the same implant system
with diameters of 3.0, 3.4, 3.8, 4.5, and
5.5 mm. They found a small correlation
between the high ISQ values and 5.5-
mm diameter implants, with a median
value of 74.02 6 11.28, a figure
considerably higher than the average
values obtained in this study, whereby
the largest diameter is 4.3 mm. In 2012,
the clinical trial of Rokn et al31 placed
304 implants from 2 implants systems
and varying diameters (3.3, 3.5, 4.1,
4.3, 4.8, and 5 mm), demonstrating that
conical implants with greater diameter
held higher ISQ values but did not spec-
ify the crown shape. In 2012, Park
et al38 performed an in vivo study with
2 different types of implants (a total of
41), establishing that the ISQ increased
the larger the diameter of the implant,
but did not reference the crown changes
of the implants, nor if they maintained
the same microtopography.
Guler et al39 examined the ISQ val-
ues of 208 Straumann implants with di-
ameters of 3.3, 4.1, and 4.8 mm. They
obtained significant differences for the
various implant diametersdat 4 weeks
(ISQ 64.6) for implants with a 4.8-mm
diameter and at 8 to 12 weeks, the
Fig. 1. A, T0. Diameter 3.7 versus 4.0 mm (P value ¼ 0.007 , 0.05) and 4.0 versus 4.3 mm (P value ¼ 0.019 , 0.05). B, T1. Diameter 4.0
versus 4.3 mm (P value ¼ 0.041 , 0.05). C and D, In T2 and T3, there are no significant differences.*Atypical cases.
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values for 4.1- and 4.8-mm implants
were significantly greater than those
for 3.3 mm, with an ISQ of 71.2 and
72.1, respectively.
Much like this study, in 2014,
Gehrke et al40 studied 100 conical im-
plants with diameters of 3.5 and 4 mm,
and obtained a statistically significant
link between the RFA findings and the
diameter (3.5, 4 mm).
In 2016, Gultekin et al41 performed
a retrospective study on a total of 103 im-
plants (from 2 different systems). The di-
ameters varied from 3.8 to 4.6 mm. They
demonstrated that the ISQ increased for
implants with larger diameters (4.6 mm
compared with 3.8 mm), both at 0 to 8
weeks and at 12 weeks. In this instance,
the difference in diameter between the im-
plants in both studies is almost double and
crown shape changes as well.
The latest studies evaluated con-
firm a positive link between high ISQ
values and a larger diameter. Such an
Fig. 2. A, T0. Diameter 4.0 V (71.53 6 11.55) versus 4.3 mm V (68.41 6 12.50) with P value ¼ 0.049 , 0.05. In diameter 4.0 L (72.40 6
11.57) versus 3.7 L (69.05 6 10.49) with P value ¼ 0.007 , 0.05. In diameter 4.0 L (72.40 6 11.57) versus 4.3 L (68.25 6 12.58) with P value
¼ 0.009 , 0.05. B, T1 In diameter 4.0 L (72.55 6 12.89) versus 4.3 L (69.13 6 12.32) with P value ¼ 0.039 , 0.05. C, T2 In diameter 4.0 L
(71.31 6 11.46) versus 3.7 L (68.20 6 11.04) with P value ¼ 0.032 , 0.05. D, T3 In diameter 4.0 V (72.85 6 11.31) versus 3.7 V (70.39 6
9.90) with P value ¼ 0.043 , 0.05.
Fig. 3. A, No significant differences in absolute ISQ values. B, In anterior maxilla, diameter 4.0 L (74.23 6 11.75) versus 3.7 L (68.65 6 8.60)
with P value ¼ 0.034 , 0.05.
284 FREQUENCY VALUES AND THEIR RELATIONSHIP ARAGONESES ET AL
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
example is thework ofKim et al,42who,
in 2017, used 573 implants from differ-
ent systems and obtained significant
values for implants ,5 mm (ISQ
78.33 6 7.12) and those $5 mm (ISQ
80.296 7.14). Another example is that
of Huang et al43 in 2017, who studied
the ISQ values obtained from 329 im-
plants from different systems and dem-
onstrated that the diameter of the
implant was a significant influencing
factor, but only when measuring the
ISQ before the final restoration. They
also concluded that the 1.5-mm diame-
ter difference found in 3.5- and 5-mm
implants could result in a difference of
5.175 to 6.296 in ISQ values, without
evaluating the changes in crown
platform.
Conversely, there are works that
argue that there is no direct and
significant link between higher ISQ
values and a larger implant diameter.
Such is the case of Bischof et al,19 who,
in 2004, studied 106 implants, or
Huwiler et al,22 who, in 2007, studied
17 implants of 4.1 and 4.8 mm andmea-
sured at the time of surgery and after at
weeks 1, 2, 3, 4, 5, 6, 8, and 12, coincid-
ing with Han et al,44 who, in 2019, per-
formed a prospective clinical study on
25 implants of the same diameter and
performing the same controls. There
were no links found in the work of Mer-
heb et al45 in 2010 either, who studied
3.3- and 4.1-mm implants in a sample
totaling 136, or in the study of Gonzá-
lez-García et al32 in 2011, who con-
cluded in a study on 68 implants from
a single system that the diameter of the
implant (3.75 and 4.25mm)did not have
a significant effect on the ISQ values.
With respect to the ISQ values
measured in this study, during the
surgery (T0), the linkwith the diameters
was of 68.64 6 11.11 for 3.7-mm im-
plants, 71.96 6 11.35 for 4-mm im-
plants, and 68.33 6 12.2 for 4.3-mm
implants. Inferior results compared
with those obtained by González-Gar-
cía et al,33 who obtained amedian value
for implants of 3.75 mm of 78.46 5.46
and of 80.83 6 5.35 for implants of
4.25mm.However, the results obtained
in this study are greater than those ob-
tained by Guler et al,39 whose values
were 62.78 6 6.95 for 3.3-mm im-
plants, 65.07 6 8.19 for 4.1-mm im-
plants, and 65.54 6 8.71 for 4.8-mm
implants. The same goes for data
obtained by Degidi et al12 in 2010:
70.32 6 11.63 for 3.0-mm implants,
71.59 6 10.03 for 3.4-mm implants,
Fig. 4. A, T1. Anterior maxilla. In diameter 4.0 (78.386 9.81) versus 3.7 (70.976 6.58) with P value ¼ 0.021, 0.05. B, T1. Anterior maxilla. In
diameter 4.0 V (78.31 6 10.80) versus 3.7 V (70.91 6 7.17) with P value ¼ 0.034 , 0.05 and for diameter 4.0 L (78.46 6 9.18) versus 3.7 L
(71.04 6 6.54) with P value ¼ 0.015 , 0.05.
Fig. 5. A, T2. Posterior maxilla. In diameter 4.0 mm (70.82 6 8.97) versus 3.7 mm (66.03 6 12.26) with P value ¼ 0.007 , 0.05 and diameter
4.0 versus 4.3 mm (67.01 6 8.59) with P value ¼ 0.044 , 0.05. B, T2. Posterior maxilla. In diameter 4.0 V (70.41 6 8.97) versus 3.7 V (66.48
6 11.15) with P value ¼ 0.021, 0.05. In diameter 4.0 L (71.226 9.33) versus 3.7 L (66.696 10.87) with P value ¼ 0.009, 0.05. In diameter
4.0 L (71.22 6 9.33) versus 4.3 L (66.65 6 9.28) with P value ¼ 0.023 , 0.05.
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71.15 6 10.47 for 3.8-mm implants,
71.94 6 11.29 for 4.5-mm implants,
and 74.02 6 11.28 for 5.5-mm im-
plants. These differences could be
attributed to the surgical protocol or
the crown countersink.
In the second surgical phase, the
results were of 70.846 9.5 for 3.7-mm
implants, 72.41 6 11.85 for 4-mm im-
plants, and 69.68 6 11.51 for 4.3-mm
implants. These figures are still way
below those obtained byGonzález-Gar-
cía et al,32 who observed greater values
in the second surgical phase than in the
first surgical phase, the opposite of this
study: 76.68 6 4.34 for 3.75-mm im-
plants and of de 78.226 6.87 for 4.25-
mm implants. In this study, ISQ values
increase over a period of 3 months for
the diameters studied. Guler et al39 also
demonstrate a fairly considerable
increase in ISQ values during the sec-
ond phase of their study (67.746 6.31
for 3.3-mm implants, 71.20 6 5.58 for
4.1-mm implants and 72.126 6.50 for
4.8-mm implants), although not all ISQ
evaluations were performed at 12
weeks. Some of their implants were
checked at 8 weeks; perhaps, this
caused the data to vary asmuch as it did.
Regarding the potential differences
between the sexes, some authors con-
sider that ISQ values are greater for men
than for women. After analyzing 905
implants, Östman et al37 concluded that
the average ISQ formen is 68.5,whereas
for women, it is 66.5. Kim et al42 estab-
lish the difference to be 79.786 6.82 for
men versus 78.34 6 7.63 for women.
Guler et al39 only found significant dif-
ferences between the sexes at 4 weeks,
which coincideswith this study, positing
that the average ISQ formenwas greater
than that for women. Furthermore, when
analyzing the difference for diameter,
we can conclude that for 3.7 mm and
for 4.3 mm, the difference is statistically
significant in favor of men. However,
there are no studies that perform these
comparisons.
Other authors such as Rokn et al31
consider that there are no differences in
ISQ between the sexes, having studied
a total of 304 implants from 2 different
systems, coinciding with the results ob-
tained by González-García et al.32
When studying the relationship
between ISQ values and implant diam-
eter and site placement in the maxilla-
ries, no works have analyzed the ISQ
values obtained in measurements for
vestibular and lingual.
Generally speaking, and much the
same as in this study, multiple authors
establish that, for the mandible, ISQ
values are greater than for the maxilla,
and they all argue that this is due to
a difference in bone density which is
why values for the mandible are greater
than for the maxilla, with a statistically
significant difference for diameters 3.7
and 4.3mm.These results coincidewith
the literature reviewed.20,38–41
When analyzing the measuring
times in this study, there are no signif-
icant differences observed in T0 as far
as absolute ISQ values are concerned.
However, in the disaggregated values,
a significant difference is observed (P
value ¼ 0.034 , 0.05) in the anterior
maxilla and in palatinewhen comparing
diameters 4.0 (74.23 6 11.75) and 3.7
(68.65 6 8.60) mm. This discrepancy
could be due to the fact that, during the
surgical phase, the countersink hole
was 4.0 mm in diameter, meaning that
3.75-mm implants bore a discrepancy
of 0.25 mm. Conversely, for 4.0-mm
implants, crown stability was perfect.
This discrepancy, in addition to a finer
vestibular cortical layer, may have pro-
duced the difference. These values are
superior to those obtained in the study
by Bischof et al,19 who studied 106 im-
plants from the same manufacturer and
concluded that for 4.1-mm implants,
values ranged from 55.4 to 60.5 (max-
illa and mandible, respectively) and for
4.8 mm from 53 to 57 (maxilla vs man-
dible). This significant difference in the
absolute ISQ values could be due to, as
argued by Snijders et al29 in 2013,
measurements being taken with differ-
ent generations of Osstell, with Osstell
Mentor values being greater.
In T1, there is a clearly greater ISQ
value for 4-mm implants (78.3869.81)
in comparison with 3.7-mm implants
(70.976 6.58) and only in the anterior
maxillary area. These values increase
that much more when referring to ISQ
values for vestibular and lingual, with
vestibular obtaining values of 78.31 6
10.80 and lingual of 78.46 6 9.18 for
4.0-mm implants compared with values
of 70.9167.17 for vestibular and 71.04
6 6.54 for lingual for 3.7-mm implants,
Fig. 6. A, T3. Anterior maxilla. In diameter 4.0 (78.736 10.41) versus 3.7 (69.856 10.11) with P value¼ 0.013, 0.05. B, T3. Anterior maxilla.
In diameter 4.0 V (79.69 6 9.55) versus 3.7 V (69.69 6 9.79) with P value ¼ 0.003 , 0.05. In diameter 4.0 L (77.77 6 11.82) versus 3.7 L
(70.02 6 10.71) with P value ¼ 0.046 , 0.05. Posterior maxilla. In diameter 4.0 V (72.00 6 9.09) versus 4.3 V (67.84 6 9.06) with P value ¼
0.033 , 0.05.
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with both comparisons presenting sig-
nificant differences. The reason could
also be due to the fact that bone in these
areas ismore sponge-like, and the larger
diameter would improve the bone–
implant contact in the crown area,
which presents the majority of cortical.
It could also be due to crown adjust-
ments during surgery or loss of crestal
bone stemming from imperfect coun-
tersink adjustment in 3.7-mm implants.
This affirmation is confirmed for 4.3-
mm implants, with an average ISQ
value of 73.26 6.26 as previouslymen-
tioned. The crown countersink is
4.0 mm in diameter, a perfect fit for im-
plants of that size. When a 4.3-mm
implant passes through the crown area,
the countersink shifts and creates a gap
of +0.3mmbetween the implant and the
bone part of the crown. In this second
period, there are also discrepancies
regarding the results obtained by Bis-
chof et al,19 who affirmed that for 4.1-
mm implants, values obtained ranged
from 57.1 to 64.7 (maxilla and mandi-
ble, respectively) and for 4.8 mm from
56.7 to 61.6 (maxilla vs mandible).
These results, despite rising similarly
to this study, are nevertheless still quite
low.
In T2, we evidence a significant
difference in the maxilla, both in abso-
lute and disaggregate ISQ values,
although in this case we are referring to
the posterior area, where values for 4.0-
mm implants (70.826 8.97) are greater
and of statistical significancewhen com-
pared with 3.7-mm implants (66.03 6
12.26). The same occurs when compar-
ing 4.0-mm implants with 4.3-mm im-
plants (67.01 6 8.59), which could be
due to a lack of adjustment or cortical
crown loss with the implantdwhich is
why they do not change over time.
At the year mark in T3, we obtain
statistically significant values in the
anterior maxillary area when compar-
ing the results for 4-mm implants (78.73
6 10.41) with those for 3.7-mm im-
plants (69.856 10.11). In the disaggre-
gate values, we observe the same results
for vestibular and lingual, with a clear
difference in the values obtained in ves-
tibular for the posterior maxilla for 4.0-
and 4.3-mm implants. This could be
due to crestal bone loss as a result of
a lack of crown adjustment.
In 2012, Park et al38 analyzed the
ISQ values of 81 implants but did not
break down the values aswe have in this
study. Nevertheless, and as opposed to
these results, theydidnot establisha link
between the ISQ value and the anterior–
posterior positioning of the implants.
Conversely, Östman et al37 obtained
higher ISQ values in posterior sections.
CONCLUSIONS
In this study on patients who are
partially edentulous, the RFAmeasured
at the time of endosseous implant
insertion and at 3, 6, and 12 months,
thereafter, showed that, as far as diam-
eter is concerned, there is no link
between greater ISQ values and larger
implant diameters. However, 4.0-mm
implants returned greater RFA values
possibly due to implant bed preparation
in the crown area.
As for the possible variations con-
cerning sex, this study established that
men’s ISQvalues are greater thanwom-
en’s. In addition, when relating back to
diameter, we observed significant dif-
ferences for 3.7- and 4.3-mmdiameters.
Regarding placement site, the re-
sults obtained coincide with the litera-
ture, andwe can confirm that the greatest
ISQ values are located in the mandible.
What is more, when relating back to
diameter, we observed significant differ-
ences for 3.7- and 4.3-mm diameters.
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